lunedì, Novembre 10, 2025

Stress in wom(b)en perpetuates consequences making ill future generations

Share

Maternal stress, encompassing physical, emotional and psychological distress, remains a widespread yet underestimated risk during pregnancy. Previous research has linked stress to increased cortisol levels and abnormal neurotransmitter signaling, which may interfere with fetal brain development. However, inconsistencies persist in understanding how prenatal stress translates into measurable cognitive and emotional outcomes in children. Environmental crises and socioeconomic inequities further compound these risks, particularly in resource-limited regions. Due to these challenges, in-depth investigations are needed to clarify how maternal stress disrupts developmental pathways and to identify strategies that can mitigate its lifelong effects.

Last month, researchers from the Georgia Institute of Technology have published a comprehensive review in Pediatric Discovery, revealing how maternal stress reshapes fetal growth and brain development through complex biological and environmental interactions. Drawing on data from major disasters such as the 1998 Ice Storm, 2008 Iowa Floods and 2010 Chile Earthquake, the team integrates molecular, physiological and sociocultural evidence. Their findings demonstrate that maternal stress activates hormonal and epigenetic changes that can persist across generations, emphasizing the urgent need for maternal mental health interventions.

The review identifies the hypothalamic-pituitary-adrenal (HPA) axis as the central stress-response system, where elevated cortisol and glucocorticoids cross the placenta and disrupt fetal brain regions such as the hippocampus and amygdala. These disruptions can impair cognitive function, emotional regulation, and later stress resilience. Imaging studies revealed reduced left hippocampal volume and altered neural connectivity in infants exposed to high prenatal anxiety. On a molecular level, chronic stress modifies DNA methylation patterns in glucocorticoid receptor genes (NR3C1), predisposing offspring to anxiety and depression.

Environmental events such as the Chile Earthquake and Project Ice Storm further demonstrate how acute and chronic stressors reshape development—leading to lower birth weights, smaller head circumferences, and increased emotional reactivity. Data from Georgia’s OASIS platform also linked maternal stress with fluctuating fetal mortality rates between 2013 and 2023, reinforcing the public health dimension of prenatal stress. The study confirms that maternal stress is not merely an emotional experience—it is a physiological signal that directly shapes the developing brain. It reinforces that reducing maternal stress is vital for improving both maternal and child health outcomes.

 Together, these findings portray maternal stress as both a biological and societal issue requiring targeted interventions. Integrating mindfulness-based stress reduction, cognitive behavioral therapy, and trauma-informed counseling into prenatal care could mitigate adverse outcomes. Policymakers are urged to prioritize structural solutions (such as paid parental leave, affordable housing, and access to mental healthcare) to alleviate socioeconomic drivers of maternal distress. In low-income countries affected by ongoing conflicts, pregnant women are often subjected to maternal stress, resulting in fetal developmental complications that perpetuate intergenerational trauma.

Future longitudinal studies are essential to trace how prenatal stress affects adolescence and adulthood. Ultimately, promoting maternal well-being is an investment in healthier, more resilient future generations.

  • Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.

Scientific references

Tadanki D et al. Pediatric Discov. 2025; 3:e70004.

Berthelon M et al. Econom Hum Biol. 2021; 43:101047.

Hanswijk SI et al. Int J Mol Sci. 2020; 21(16):5850.

Dott. Gianfrancesco Cormaci
Dott. Gianfrancesco Cormaci
Laurea in Medicina e Chirurgia nel 1998; specialista in Biochimica Clinica dal 2002; dottorato in Neurobiologia nel 2006. Ricercatore negli USA (2004-2008) alle dipendenze dell'NIH/NIDA e poi della Johns Hopkins University. Guardia medica presso la Clinica Basile di Catania (dal 2013) e continuo presso la casa di Cura Sant'Agata a Catania (dal 2020). Detentore di un brevetto per la fabbricazione di sfarinati gluten-free a partire da regolare farina di grano. Responsabile della sezione R&D della CoFood s.r.l. per la ricerca e sviluppo di nuovi prodotti alimentari, inclusi quelli a fini medici speciali. Medico penitenziario da Aprile 2024 presso la CC.SR. Cavadonna

Read more

Local News